Further analysis indicated that inhibiting BMP signaling in astrocytes could reduce the expression of inflammation-related genes (such as Nlrp3, TNF-α, and IL-1β), thereby rescuing the loss of dopaminergic neurons and improving motor function in PD model mice. The gene discussed is IL1B; the disease is Parkinson disease.